| Product Description | Glucomap is a rational combination of herbal hypoglycaemias known since ages and duly accredited by laboratory and clinical studies. Glucomap has both pancreatic as well as extra pancreatic action (Momordica cherantia and Eugenia jambolana). Glucomap stimulates beta cells of pancreas (Aegle marmelos), increases peripheral utilisation of glucose and arrests glycogenolysis. Glucomap protects cardiovascular and nerve tissues from degenerative changes (Terminaliaarjuna), protects the liver and strengthens its function (phyllanthus niruri). The immuno-regulator, Asphaltum in Glucomap arrests metabolic abnormalities and reduces recurrent infections. Salsaradigan of Glucomap gives an umbrella of protection against all pervasive degeneration in diabetes Helps alone or as an adjuvant with other OHA in stabilizing blood sugar in type II patients. During clinical trials, Glucomap was found to be extremely well tolerated even in doses as high as 16 tablets a day. Significantly, almost all patients had such improved subjective feelings as never experienced with other anti-diabetic therapies. |
| Indication | Non- insulin dependent Diabetes mellitus. As an adjuvant to other anti-diabetic drugs. |
| Composition | Each 500mg tablet contains Enicostemma littorale 33.33mg Phyllanthus niruri 33.33mg Eugenia jambolana 33.33mg (leaf) Eugenia jambolana (seed) 133.33mg Azadirachta indica 33.33mg Terminalia arjuna 33.33mg Aegle marmelos 133.33mg Asphaltum 66.66mg |
| Dosage | 1-2 Tablets twice a day or as directed by the physician. |
For easy access and quick orders
Connect with Us
